Nonspecified Subtype of 11beta-Hydroxysteroid Dehydrogenase in Hormone Regulation and Disease

Target Name: 11beta-Hydroxysteroid Dehydrogenase

NCBI ID: P10262

11beta-Hydroxysteroid Dehydrogenase

Other Name(s): Short chain dehydrogenase/reductase family 26C member | 11beta-HSD | Hydroxysteroid (11-beta) dehydrogenase | Corticosteroid 11-beta-dehydrogenase | 11-DH

Nonspecified Subtype of 11beta-Hydroxysteroid Dehydrogenase in Hormone Regulation and Disease

11beta-Hydroxysteroid Dehydrogenase (nonspecified subtype), also known as Short chain dehydrogenase or redirectase family 26C member, is a gene that encodes a protein involved in the metabolism of 11beta-hydroxysteroids, which are naturally occurring compounds found in the body. 11beta-hydroxysteroids are involved in various physiological processes in the body, including hormone regulation, inflammation, and cell signaling. The nonspecified subtype of 11beta-hydroxysteroid dehydrogenase is a gene that has not yet been studied extensively, but it is possible that it may play a significant role in the regulation of these compounds.

The 11beta-hydroxysteroid dehydrogenase gene is a member of the Short chain dehydrogenase or redirectase family 26C, which is a subset of the Superfamily of cytoskeletal proteins (SOCP) that also includes genes involved in the metabolism of other types of proteins, including tyrosine hydroxylase, tryptophan hydroxylase, and dopamine oxidase. These genes are involved in the production of reactive oxygen species (ROS), which can cause damage to cells and contribute to a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The nonspecified subtype of 11beta-hydroxysteroid dehydrogenase is a gene that has not yet been studied extensively, but it is possible that it may play a significant role in the regulation of 11beta-hydroxysteroids. This is because the gene is known to encode a protein that is involved in the metabolism of 11beta-hydroxysteroids, which are naturally occurring compounds in the body that are involved in various physiological processes.

The 11beta-hydroxysteroid dehydrogenase gene has been shown to be involved in the production of ROS, which can cause damage to cells and contribute to a variety of diseases. For example, studies have shown that ROS can cause damage to the brain and contribute to the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, ROS can cause damage to the skin and contribute to the development of skin diseases, such as acne and rosacea.

In addition to its role in the production of ROS, the 11beta-hydroxysteroid dehydrogenase gene is also involved in the regulation of 11beta-hydroxysteroids. This is because the gene is known to encode a protein that is involved in the metabolism of 11beta-hydroxysteroids, which are naturally occurring compounds in the body that are involved in various physiological processes.

The nonspecified subtype of 11beta-hydroxysteroid dehydrogenase is a gene that has not yet been studied extensively, but it is possible that it may play a significant role in the regulation of 11beta-hydroxysteroids. This is because the gene is known to encode a protein that is involved in the metabolism of these compounds, and it is possible that it may be involved in the regulation of their levels in the body.

Overall, the nonspecified subtype of 11beta-hydroxysteroid dehydrogenase is a gene that is involved in the metabolism of 11beta-hydroxysteroids, which are naturally occurring compounds in the body that are involved in various physiological processes. While more research is needed to fully understand the role of this gene in the regulation of 11beta-hydroxysteroids, it is possible that it may play a significant role in the development and progression of a variety of diseases.

Protein Name: 11beta-Hydroxysteroid Dehydrogenase (nonspecified Subtype)

The "11beta-Hydroxysteroid Dehydrogenase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about 11beta-Hydroxysteroid Dehydrogenase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets